Chlordiazepoxide Hydrochloride And Clidinium Bromide Capsule
Product Images NDC 46708-744

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Chlordiazepoxide Hydrochloride And Clidinium Bromide (NDC 46708-744). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

100 Capsules (Chlordiazepoxide Clidinium Caps 5 25 mg)

Label for Chlordiazepoxide Hydrochloride and Clidinium Bromide Capsules, USP 5 mg/2.5 mg, manufactured by Alembic Pharmaceuticals Limited. The label indicates the product contains 100 capsules, is for oral use, and is a prescription drug. Dosage storage instructions and dosage guidance are included, along with a barcode and NDC 46708-744-31.*

FDA Label Image

Chlordiazepoxide-clidinium-str1.jpg (Chlordiazepoxide Clidinium Str1)

Chemical structure of Chlordiazepoxide hydrochloride, showing its core diazepine ring with chlorine and phenyl substitutions, and bonded hydrochloride component.*

FDA Label Image

Chlordiazepoxide-clidinium-str2.jpg (Chlordiazepoxide Clidinium Str2)

Chemical structure diagram of chlordiazepoxide hydrochloride and clidinium bromide, showing molecular bonds and ring structures typical of these compounds.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.